Revenue
2022
2023
2024
2025
Bright Minds Biosciences Inc. (DRUG)
Price$49.82Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $11.1M | $1.2M | $5.0M | $12.2M | $6.3M | $354,852 |
| Operating expenses | $13.9M | $2.8M | $7.4M | $15.0M | — | — |
| Operating income | −$13.9M | −$2.8M | −$7.4M | −$15.0M | — | — |
| EBITDA | −$13.9M | −$2.7M | −$7.3M | −$15.0M | — | — |
| Net income | −$12.2M | −$2.8M | −$7.4M | −$15.0M | −$8.7M | −$480,377 |
| Basic EPSper basic share | -CA$1.78 | -CA$0.65 | -CA$1.98 | -CA$6.06 | -CA$4.82 | -CA$0.13 |
| Diluted EPSper diluted share | -CA$1.78 | -CA$0.65 | -CA$1.98 | -CA$6.06 | -CA$4.82 | -CA$0.13 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Jupiter Topco LLC | 1.35M |
Cormorant Asset Management, LP | 900K |
BlackRock, Inc. | 686.18K |
Vivo Capital, LLC | 557.17K |
Vestal Point Capital, LP | 545K |
BRAIDWELL LP | 483.82K |
Driehaus Capital Management LLC | 433.38K |
Balyasny Asset Management L.P. | 345.05K |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 335K |
Point72 Asset Management, L.P. | 327.42K |
DEERFIELD MANAGEMENT COMPANY, L.P. | 283K |
RA CAPITAL MANAGEMENT, L.P. | 265K |
Parkman Healthcare Partners LLC | 205.05K |
MPM BIOIMPACT LLC | 202.11K |
WELLINGTON MANAGEMENT GROUP LLP | 171.32K |
GOLDMAN SACHS GROUP INC | 133.69K |
EVENTIDE ASSET MANAGEMENT, LLC | 130.01K |
STATE STREET CORP | 122.18K |
SEVEN GRAND MANAGERS, LLC | 120K |
GREAT POINT PARTNERS LLC | 109.6K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 28, 2026Form 4 | Cormorant Asset Management, LP +2Other | SellCommon Shares · indirect | 109.3K | $89.50 | $9.79M | 950.0K |
| Nov 4, 2024Form 4 | Cormorant Asset Management, LP +1TenPercentOwner | BuyCommon Shares · indirect | 184.3K | $21.70 | $4.00M | 1.06M |
| Oct 16, 2024Form 4 | Cormorant Global Healthcare Master Fund, LP +2TenPercentOwner | BuyCommon Shares · indirect | 3.1K | $25.22 | $78.4K | 875.0K |
| Oct 16, 2024Form 4 | Cormorant Global Healthcare Master Fund, LP +2TenPercentOwner | BuyCommon Shares · indirect | 7.2K | $24.03 | $171.8K | 871.9K |
| Oct 16, 2024Form 4 | Cormorant Global Healthcare Master Fund, LP +2TenPercentOwner | BuyCommon Shares · indirect | 39.7K | $23.22 | $922.8K | 864.7K |